The Crypto BasicStocks
Moderna Stock Erases Nearly 10% Premarket Gain Despite Earnings Beat
Moderna (NASDAQ: MRNA) shares reversed an early 9.6% premarket gain on Friday, despite the vaccine maker reporting better-than-expected third-quarter earnings and raising its 2026 revenue growth...

